FIELD: medicine, pharmacology. SUBSTANCE: invention relates to the use of iodoantipyrine as an agent decreasing the mutagenic effect of cyclophosphane. Using of said preparation ensures to provide an antimutagenic effect. EFFECT: valuable property of agent. 1 cl, 17 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION AND CORRECTION OF CYTOGENETIC DISORDER | 2012 |
|
RU2504392C1 |
MEDICINAL AGENT ELICITING ANTIMUTAGENIC EFFECT | 2004 |
|
RU2258528C1 |
MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
ANTIMUTAGENIC AGENT | 2019 |
|
RU2698204C1 |
METHOD OF OCCUPATIONAL SELECTION OF PERSONS FOR WORK ON DESTRUCTION OF CHEMICAL WARFARE AGENTS | 2016 |
|
RU2642603C2 |
PREPARATION OF ANTIMUTAGENIC ACTIVITY | 2004 |
|
RU2277417C1 |
ANTIMUTAGEN | 2004 |
|
RU2266128C1 |
RADIOPROTECTIVE AGENT | 1997 |
|
RU2179020C2 |
METHOD FOR ANTIMUTAGENIC EFFECT ON BODY | 2003 |
|
RU2261704C2 |
METHOD FOR DETECTING GENOMIC INSTABILITY IN CHILDREN WITH JUVENILE CEREBRAL PALSY | 2005 |
|
RU2295130C1 |
Authors
Dates
2002-09-20—Published
2000-07-10—Filed